FCM
Farallon Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-604,098
| Closed | -$172M | – | 166 |
|
|
2023
Q2 | $172M | Sell |
604,098
-15,700
| -3% | -$4.47M | 0.86% | 34 |
|
|
2023
Q1 | $172M | Buy |
619,798
+27,099
| +5% | +$7.53M | 0.94% | 37 |
|
|
2022
Q4 | $164M | Buy |
592,699
+287,200
| +94% | +$79.5M | 0.97% | 37 |
|
|
2022
Q3 | $81.6M | Buy |
305,499
+27,000
| +10% | +$7.21M | 0.45% | 56 |
|
|
2022
Q2 | $56.8M | Buy |
278,499
+80,700
| +41% | +$16.5M | 0.31% | 68 |
|
|
2022
Q1 | $41.7M | Buy |
197,799
+50,090
| +34% | +$10.5M | 0.2% | 77 |
|
|
2021
Q4 | $35.4M | Sell |
147,709
-23,150
| -14% | -$5.55M | 0.18% | 74 |
|
|
2021
Q3 | $48.4M | Buy |
170,859
+61,859
| +57% | +$17.5M | 0.23% | 75 |
|
|
2021
Q2 | $37.7M | Buy |
109,000
+6,000
| +6% | +$2.08M | 0.15% | 81 |
|
|
2021
Q1 | $28.8M | Hold |
103,000
| – | – | 0.14% | 88 |
|
|
2020
Q4 | $25.2M | Buy |
+103,000
| New | +$25.2M | 0.15% | 84 |
|
|
2018
Q3 | – | Sell |
-249,000
| Closed | -$72.3M | – | 102 |
|
|
2018
Q2 | $72.3M | Sell |
249,000
-91,000
| -27% | -$26.4M | 0.45% | 42 |
|
|
2018
Q1 | $93.1M | Sell |
340,000
-200,000
| -37% | -$54.8M | 0.64% | 34 |
|
|
2017
Q4 | $172M | Buy |
540,000
+65,000
| +14% | +$20.7M | 1.4% | 19 |
|
|
2017
Q3 | $149M | Buy |
475,000
+262,500
| +124% | +$82.2M | 1.32% | 17 |
|
|
2017
Q2 | $57.7M | Buy |
+212,500
| New | +$57.7M | 0.6% | 33 |
|